Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Imunon Inc IMNN

Healthcare Biotechnology

Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases. The Company is developing non-viral Deoxyribonucleic acid (DNA) technology across four modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment... see more

Add To Watchlist

Recent & Breaking News (NDAQ:IMNN)

Today's Research on HSP, ALKS, CLSN, THRX, and CHTP

Accesswire May 13, 2013

Celsion Corporation Reports First Quarter 2013 Financial Results and Provides Business Update

PR Newswire May 9, 2013

Celsion Announces ThermoDox® HEAT Study Findings to be Reviewed at the 9th Annual World Conference on Interventional Oncology (WCIO) in New York City on May 16, 2013

PR Newswire May 1, 2013

Celsion Corporation to Hold First Quarter 2013 Financial Results Conference Call on Thursday, May 9, 2013

PR Newswire May 1, 2013

Celsion Corporation Provides Business Update

PR Newswire April 23, 2013

Today's Research on Celsion, Zogenix, Actavis, and Avanir Pharma

PR Newswire April 10, 2013

Free Research Reports on CLSN, CREE, HALO and TSO Issued by the Bedford Report

Marketwired April 8, 2013

Celsion Corporation Reports Year End 2012 Financial Results and Provides Business Update

PR Newswire March 18, 2013

Celsion Corporation to Hold Year-End 2012 Financial Results Conference Call On Monday, March 18, 2013

PR Newswire March 12, 2013

Pre-Market Analysis on Celsion, Velti, Heckmann, FuelCell Energy, and Diamond Foods

PR Newswire March 12, 2013

Celsion Corporation Announces $15 Million Registered Direct Offering

PR Newswire February 22, 2013

Free Research Report on NII Holdings, Inc., Denbury Resources Inc., Celsion Corp., ONEOK, Inc. and Ryland Group, Inc. (The)

Marketwired February 13, 2013

Free Research Reports on ONCY, CLSN, ETRM and MOH Issued by the Bedford Report

Marketwired February 11, 2013

Celsion Corporation Provides an Update Regarding ThermoDox® Agreements with Zhejiang HISUN Pharmaceutical Company for China

PR Newswire February 5, 2013

Free Research Reports on APPY, ATHX, CLSN and DCTH Issued by the Bedford Report

Marketwired February 5, 2013

Free Research Reports on BIOF, CLSN, FTNT and SWKS Issued by the Bedford Report

Marketwired February 1, 2013

Biotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year High

Marketwired February 1, 2013

Law Firm Brower Piven Announces Investigation of Investor Securities Fraud Against Celsion Corporation

Business Wire January 31, 2013

Celsion Announces Results of Phase III HEAT Study of ThermoDox® in Primary Liver Cancer

PR Newswire January 31, 2013

Celsion Corporation to Host Conference Call and Webcast on January 31, 2013 at 8:00 AM EST to Present Top-Line Data from its Pivotal Phase III HEAT Study

PR Newswire January 30, 2013